Pathogenetic mechanisms and treatment principles of chronic thromboembolic pulmonary hypertension

被引：0
|
作者：
Shostak, N. A. [1 ]
Klimenko, A. A. [1 ]
Demidova, N. A. [1 ]
Novikov, I. V. [1 ]
机构：
[1] Russian State Med Univ, Ostrovitjanova 1, Moscow 117997, Russia
来源：
RATIONAL PHARMACOTHERAPY IN CARDIOLOGY | 2011年 / 7卷 / 02期
关键词：
pulmonary hypertension; chronic thromboembolic pulmonary hypertension; thromboembolism of pulmonary artery; thromboendarterectomy; bosentan; prostacyclin analogues; phosphodiesterase-5; inhibitors;
D O I：
10.20996/1819-6446-2011-7-2-199-203
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Data about chronic thromboembolic pulmonary hypertension (CTPH) prevalence is presented. The main CTPH clinical manifestations are described. The possible reasons and pathogenetic mechanisms of CTPH development are discussed. Features of unfavorable disease prognosis are also presented. Indications, results, limitations for CTPH surgical treatment are shown. Data of the currently completed clinical studies on bosentan, prostacyclin analogues and phosphodiesterase-5 inhibitors usage in CTPH are presented.
引用
收藏
页码：199 / 203
页数：5
相关论文
共 50 条
  • [11] Multimodality treatment for chronic thromboembolic pulmonary hypertension
    Wiedenroth, Christoph B.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 278 : 238 - 239
  • [12] Surgical treatment of chronic thromboembolic pulmonary hypertension
    Dartevelle, P
    Fadel, E
    Mussot, S
    Cerrina, J
    Ladurie, EL
    Lehouerou, D
    Parquin, E
    Paul, JE
    Musset, D
    Humbert, M
    Sitbon, O
    Parent, E
    Simonneau, G
    PRESSE MEDICALE, 2005, 34 (19): : 1475 - 1486
  • [13] Prevention and treatment of the chronic thromboembolic pulmonary hypertension
    Pesavento, Raffaele
    Prandoni, Paolo
    THROMBOSIS RESEARCH, 2018, 164 : 150 - 156
  • [14] Chronic Thromboembolic Pulmonary Hypertension: Endovascular Treatment
    Ahn, Chul-Min
    Hiromi, Matsubara
    KOREAN CIRCULATION JOURNAL, 2019, 49 (03) : 214 - 222
  • [15] Treprostinil for the treatment of chronic thromboembolic pulmonary hypertension
    Sadushi-Kolici, Roela
    Lang, Irene Marthe
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2019, 13 (09) : 807 - 813
  • [16] Pathophysiology and Treatment of Chronic Thromboembolic Pulmonary Hypertension
    Otani, Naoyuki
    Watanabe, Ryo
    Tomoe, Takashi
    Toyoda, Shigeru
    Yasu, Takanori
    Nakamoto, Takaaki
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)
  • [17] Selexipag for the treatment of chronic thromboembolic pulmonary hypertension
    Ogo, Takeshi
    Shimokawahara, Hiroto
    Kinoshita, Hideyuki
    Sakao, Seiichiro
    Abe, Kohtaro
    Matoba, Satoaki
    Motoki, Hirohiko
    Takama, Noriaki
    Ako, Junya
    Ikeda, Yasuhiro
    Joho, Shuji
    Maki, Hisataka
    Saeki, Takahiro
    Sugano, Teruyasu
    Tsujino, Ichizo
    Yoshioka, Koichiro
    Shiota, Naoki
    Tanaka, Shinichi
    Yamamoto, Chieko
    Tanabe, Nobuhiro
    Tatsumi, Koichiro
    Study Grp, Study Group
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60 (01)
  • [18] Medical Treatment Of Chronic Thromboembolic Pulmonary Hypertension
    Browne, E.
    Echevarria, C.
    Lordan, J.
    Fisher, A.
    MacGowan, G.
    Parry, G.
    Crackett, R.
    Day, M.
    DeSoyza, J.
    Corris, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [19] Surgical treatment of chronic thromboembolic pulmonary hypertension
    Jenkins, David P.
    Madani, Michael
    Mayer, Eckhard
    Kerr, Kim
    Kim, Nic
    Klepetko, Walter
    Morsolinl, Marco
    Dartevelle, Philippe
    EUROPEAN RESPIRATORY JOURNAL, 2013, 41 (03) : 735 - 742
  • [20] Medical treatment in chronic thromboembolic pulmonary hypertension
    Wieteska, Maria
    Kurzyna, Marcin
    Torbicki, Adam
    KARDIOLOGIA POLSKA, 2010, 68 (03) : 327 - 331
12345